PHARMA NORD APS has a total of 26 patent applications. Its first patent ever was published in 1995. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are BIOFERMIN PHARMACEUTICAL CO LTD, HOUSE WELLNESS FOODS CORP and YAMADA BEE CO INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Hungary | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Denmark | 1 | |
#8 | Finland | 1 | |
#9 | Hong Kong | 1 | |
#10 | Norway | 1 | |
#11 | Sweden | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Microorganisms | |
#5 | Edible oils | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Moesgaard Sven | 21 |
#2 | Paulin Helge Schousen | 5 |
#3 | Paulin Helge Skousen | 5 |
#4 | Henriksen Bent | 2 |
#5 | Björnstedt Mikael | 2 |
#6 | Walker Ulrich | 2 |
#7 | Skousen Paulin Helge | 1 |
#8 | Paulin Helge | 1 |
#9 | Sven Moesgaard | 1 |
#10 | Alehagen Urban | 1 |
Publication | Filing date | Title |
---|---|---|
US2019008798A1 | Coenzyme Q10 in the preventive treatment of type 2 diabetes | |
WO2017102970A1 | Dosage regimen of sodium selenite in the treatment of cancer | |
HUE042702T2 | Recrystallization of ubidecarenone for improved bioavailability | |
WO2016038150A1 | Ubidecarenone composition | |
DK200200408A | Selenium yeast product, process for the preparation of a selenium yeast product and use of the product for the manufacture of a food, a dietary supplement, or a drug | |
EP1365755A2 | Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies | |
EP0913155A2 | Pharmaceutical formulation for treating liver disorders | |
EP0804927A1 | Multi-antioxidant medicament | |
SE9500610D0 | Tooth care substance |